# Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.

Study · id `cardio:ct-nct07308925` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07308925](<https://clinicaltrials.gov/study/NCT07308925>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07308925

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 108 participants.

## Technical summary

Registry record NCT07308925. Randomized; no masking; primary purpose treatment. Start 2026-01-31 (anticipated); primary completion 2028-05-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 108 participants (planned count; ClinicalTrials.gov record NCT07308925, source copy `cardio:ctgov-nct07308925-2025-12-30`, retrieved 2026-10-26)
- Planned start: 2026-01-31 (anticipated) (ClinicalTrials.gov record NCT07308925, source copy `cardio:ctgov-nct07308925-2025-12-30`, retrieved 2026-10-26)
- Primary completion: 2028-05-31 (anticipated) (ClinicalTrials.gov record NCT07308925, source copy `cardio:ctgov-nct07308925-2025-12-30`, retrieved 2026-10-26)
- Completion: 2028-12-30 (anticipated) (ClinicalTrials.gov record NCT07308925, source copy `cardio:ctgov-nct07308925-2025-12-30`, retrieved 2026-10-26)
- Countries: Colombia (ClinicalTrials.gov record NCT07308925, source copy `cardio:ctgov-nct07308925-2025-12-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07308925-2025-12-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.
- Condition: Type 2 Diabetes
- Intervention (Device): real time Continuous Glucose Monitoring
- Lead sponsor: Hospital Universitario San Ignacio
- Lead sponsor class: OTHER
- Collaborator: Pontificia Universidad Javeriana
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 976f88d87a8253621b97e130dc026fb7ab418dd9f2f7a216360151ebb5666ea6
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
